Buscar
Anbio Biotechnology
NNNNAñadir a la lista de seguimiento
9.900USD
-0.850-7.91%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
434.52MCap. mercado
67.52P/E TTM
Más Datos de Anbio Biotechnology Compañía
Anbio Biotechnology is a Germany-based medical device company. The Company is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products offer solutions for over the counter (OTC) use, point-of-care (POCT) settings, and laboratory applications, ensuring that both healthcare providers and patients have access to reliable and efficient diagnostic tools in any setting. Its IVD products detect a wide range of biomarkers across critical medical fields, including infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Some of its IVD platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR) and Loop-mediated Isothermal Amplification (LAMP).
Información de Anbio Biotechnology
Símbolo de cotizaciónNNNN
Nombre de la empresaAnbio Biotechnology
Fecha de salida a bolsaFeb 19, 2025
Director ejecutivoLau (Michael)
Número de empleados27
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 19
DirecciónFriedrich-Ebert-Anlage 49
CiudadFRANKFURT AM MAIN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísGermany
Código postal60308
Teléfono4916096247281
Sitio Webhttps://anbiobiotechnology.com/
Símbolo de cotizaciónNNNN
Fecha de salida a bolsaFeb 19, 2025
Director ejecutivoLau (Michael)
Ejecutivos de Anbio Biotechnology
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael Lau
Mr. Michael Lau
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Suki Song
Ms. Suki Song
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Chris Tiantian
Mr. Chris Tiantian
Chief Business Officer
Chief Business Officer
--
--
Mr. Cany Xu
Mr. Cany Xu
Executive Director
Executive Director
--
--
Ms. Nancy Hartzler
Ms. Nancy Hartzler
Independent Director
Independent Director
--
--
Mr. Kenneth Li
Mr. Kenneth Li
Independent Director
Independent Director
--
--
Mr. David Hsu
Mr. David Hsu
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael Lau
Mr. Michael Lau
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Suki Song
Ms. Suki Song
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Chris Tiantian
Mr. Chris Tiantian
Chief Business Officer
Chief Business Officer
--
--
Mr. Cany Xu
Mr. Cany Xu
Executive Director
Executive Director
--
--
Ms. Nancy Hartzler
Ms. Nancy Hartzler
Independent Director
Independent Director
--
--
Mr. Kenneth Li
Mr. Kenneth Li
Independent Director
Independent Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Anbio Biotechnology?
Los cinco principales accionistas de Anbio Biotechnology son: Mr. Michael Lau
¿Cuántas instituciones poseen acciones de Anbio Biotechnology (NNNN)?
A fecha de 2026Q1, 13 instituciones poseen acciones de Anbio Biotechnology, con un valor de mercado combinado de aproximadamente 2.13M, lo que representa el 4.86% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 2063041.00.